celecoxib has been researched along with ilomastat in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Clevert, DA; Cyran, CC; Gires, O; Ingrisch, M; Mack, B; Nikolaou, K; Paprottka, PM; Reiser, MF; Roßpunt, S; Zengel, P | 1 |
2 other study(ies) available for celecoxib and ilomastat
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Reducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hydroxamic Acids; Hypopharyngeal Neoplasms; Indoles; Neovascularization, Pathologic; Oximes; Piperazines; Rats; Sulfonamides; Treatment Outcome; Ultrasonography; Xenograft Model Antitumor Assays | 2015 |